Skip to content
Search

Latest Stories

RPS celebrates ‘outstanding contributions to the pharmacy field’ with three new awards

An award has been created to honour RPS Fellow Nina Barnett,who played an instrumental part in developing the society's mentoring programme

 The Royal Pharmaceutical Society (RPS) announced three new awards – the Daniel Thomas Award, the OPERA Award and the Barnett Award – at its annual conference on Friday.


RPS President Professor Claire Anderson said each award recognises “exceptional contributions to the pharmacy field.”

The Daniel Thomas Award recognises pharmacists or pharmaceutical scientists who died while actively practising in the profession.

It is named after Daniel Thomas, a pharmacist who died during the First World War in 1917 while serving with the Royal Army Medical Corps.

The Outstanding Pharmacy Early-Career Researcher Award or OPERA Award recognises the achievements of early-career researchers within the pharmacy field.

The Barnett Award recognises those who have instilled a culture of excellence in mentoring and professional development.

It has been created to honour RPS Fellow Nina Barnett, who played an instrumental part in developing the RPS mentoring programme.

She dedicated her life to coaching and mentoring members of the healthcare family.

RPS Fellow Nina Barnett became the first winner of the Daniel Thomas Award.

Nina’s husband, Andre Ingram, who accepted the award on her behalf, said: “I am honoured to accept the Daniel Thomas Award on behalf of my wonderful wife, Nina.

“She would have wanted me to thank everyone she worked with who enabled her to excel at a career she loved.”

Stephen Kelly, a lecturer in pharmaceutical microbiomics at the Queen’s University Belfast School of Pharmacy, was presented the OPERA Award.

He is recognised for his research on microbiome analysis and its functional exploitation for pharmaceutical and healthcare applications.

Stephen said: “I am delighted to receive the 2023 OPERA prize in recognition of our research into the effects of the microbiome on health outcomes. This award reflects the hard work of various collaborative projects and highlights the impact of investigating such an important area of pharmacy research.”

Stephen also gave a presentation at the annual conference.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less